Abstract
The idea that the induction of cancer might follow mutation of somatic cells was first put forward by Boveri in 19141. He suggested that the great frequency of mitotic abnormalities in cancers indicates an abnormal chromosome constitution which might be the primary cause of malignant change in the cells. The presence of visible chromosomal abnormalities is not, however, an essential feature of malignancy and the ideas of Boveri have been critically reviewed by Koller 2 in the light of more recent cytological analysis. Koller points out that primary tumours always contain some cells of normal karyotype and that these may be the only type, particularly during the early stages of tumour development. Furthermore, there is evidence that mitotic abnormalities and cell heterogeneity in tumours may be the result of defective nutritional and blood supply within the tumour mass and thus a secondary effect rather than the primary cause of the malignant change. It seems, therefore, that morphologically detectable chromosome abnormalities have not been established as the cause of the neoplastic transformation but this does not exclude chromosomal changes which cannot be detected microscopically but which may occur in the induction of point mutations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Boveri, T. H.: Zur Frage der Entstehung maligner Tumoren. Jena: Fischer 1914.
Koller, P. C.: In Cell Physiology of Neoplasis. Austin: University of Texas Press 1960.
Darlington, C. D.: Brit. J. Cancer 2, 118 (1948).
Furth, J., and M. C. Kahn: Amer. J. Cancer 31, 276 (1937).
Klein, E.: Exp. Cell Res. 8, 213 (1955).
Fisher, B., and E. R. Fisher: Science 130, 918 (1959).
Jacob, F., and J. Monod: Cold Spr. Harb. Symp. Quart, Biol. 26,193 (1961).
Pitot, H. C., and C. Heidelberger: Cancer Res. 23, 1694 (1963).
Burdette, W. J.: Cancer Res. 15, 201 (1955).
Rous, P.: Nature (Lond.) 183, 1357 (1959).
Burnet, F. M.: Brit. med. J. 1, 779 (1957).
Kaplan, H. S.: Cancer Res. 19, 791 (1959).
Pullman, B.: J. cell comp. Physiol. 64, 91 (1964).
Clayson, D. B.: Chemical Carcinogenesis. London: J. & A. Churchill 1962.
Pasternak, L.: Arzneimittel-Forsch. 14, 802 (1964).
Magee, P. N., and R. Schoental: Brit. med. Bull. 20, 102 (1964).
Magee, P. N, and J. M. Barnes: Advanc. Cancer Res. (In press).
Auerbach, C., and J. M. Robson: Nature (Lond.) 157, 302 (1946).
Brookes, P., and P. D. Lawley: J. cell. comp. Physiol. 64, 111 (1964).
Walpole, A. L., D. C. Roberts, F. L. Rose, J. A. Hendry, and R. F. Homer: Brit. J. Pharmacol. 9, 306 (1954).
Roe, F. J. C., and O. M. Glendenning: Brit. J. Cancer 10, 357 (1956).
Peters, R. A.: Nature (Lond.) 159,149 (1947).
Ross, W. C.: Biological Alkylating Agents. London: Butterworth 1962.
Freese, E.: In Molecular Genetics. Part I., ed. by Taylor, J. H. New York: Academic Press 1963.
Haddow, A.: Brit. med. Bull. 14, 79 (1958).
Magee, P. N., and J. M. Barnes: Brit. J. Cancer 10, 114 (1956).
Druckrey, H., R. Preussmann, and D. Schmähl: Acta Un. int. Cancr. 19, 510 (1963).
Druckrey, H., R. Preussmann, D. Schmähl und M. Müller: Naturwissenschaften 48, 165 (1961).
Schoental, R.: Nature (Lond.) 188, 420 (1960).
Arcos, J. C., and M. Arcos: Fortschr. Arzneimittel-Forsch. 4, 407 (1962).
Weisburger, J. H., and E. K. Weisburger: Clin. Pharmacol. Ther. 4, 110 (1963).
Miller, E. C., and J. A. Miller: Pharmacol. Rev. 18, 805 (1966).
Barnes, J. M., and P. N. Magee: Brit. J. industr. Med. 11, 167 (1954).
Magee, P. N., and J. M. Barnes: J. Path. Bact. 84, 19 (1962).
Druckrey, H., D. Steinhofe, R. Preussmann und S. Ivankovic: Naturwissenschaften 50, 735 (1963).
Druckrey, H, S. Ivankovic und R. Preussmann: Naturwissenschaften 51,144 (1964).
Graffi, A., and F. Hoffmann: Acta biol. med. germ. 16, K 1 (1966).
Leaver, D. D., P. F. Swann, and P. N. Magee: Unpublished work.
Druckrey, H., R. Preussmann, S. Ivankovic, C. H. Schmidt, H. D. Mennel und K. V. Stahl: Z. Krebsforsch. 66, 280 (1964).
Druckrey, H., R. Preussmann, G. Blum, S. Ivankovic und J. Afkham: Naturwissenschaften 50, 100 (1963).
Dutton, A. H., and D. F. Heath: Nature (Lond.) 178, 644 (1956).
Magee, P. N.: Biochem. J. 64, 676 (1956).
Heath, D. F.: Biochem. J. 85, 72 (1962).
Magee, P. N., and M. Vandekar: Biochem. J. 70, 600 (1958).
Brouwers, J. A. J., and P. Emmelot: Exp. Cell Res. 19, 467 (1960).
Brodie, B. B., J. R. Gillette, and B. N. La Du: Ann. Rev. Biochem. 27, 427 (1958).
Schoental, R.: Nature (Lond.) 192, 670 (1961).
Magee, P. N., and T. Hultin: Biochem. J. 83, 106 (1962).
Magee, P. N, and E. Färber: Biochem. J. 83,114 (1962).
Lee, K. Y., W. Lijinsky, and P. N. Magee: J. nat. Cancer Inst. 32, 65 (1964).
Druckrey, H., D. Steinhoff, H. Beuthner, H. Schneider und P. Klärner: Arzneimittel-Forsch. 13, 320 (1963).
Lochmann, E. R., u. W. Stein: Z. Naturforsch. 18 b, 809 (1963).
Gierer, A., and K. W. Mundry: Nature (Lond.) 182, 1457 (1958).
GiererV. M., and P. N. Magee: Biochem. J. (In press).
Süss, R.: Z. Naturforsch. 20 b, 714 (1965).
Druckrey, H., R. Preussmann, N. Nashed und S. Iyankoyic: Z. Krebsforsch. 68,103 (1966).
Terracini, B., and P. N. Magee: Unpublished work.
Swann, P., V. M. Craddock, and P. N. Magee: Second Meeting Federat. Europ. Biochem. Soc. p. 322 (1965).
Craddock, V. M., and P. N. Magee: Biochem. J. 89, 32 (1963).
Krüger, M., u. G. Salomon: Z. physiol. Chem. 24, 364 (1898).
Mandel, L. R., P. R. Sriniyasan, and E. Borek: Nature (Lond.) 209, 586 (1966).
Craddock, V. M., and P. N. Magee: Unpublished work.
Takayama, S., and K. Oota: Gann 54, 465 (1963).
Tomatis, L., P. N. Magee, and P. Shubik: J. nat. Cancer Inst. 33, 341 (1964).
Halver, J. E., C. L. Johnson, and L. M. Ashley: Fed. Proc. 21, 390 (1962).
Schmähl, D., R. Preussmann und H. Hamperl: Naturwissenschaften 47, 89 (1960).
Schmähl, D, C. Thomas und K. König: Naturwissenschaften 50, 407 (1963).
Herrold, K. M., and L. J. Dunham: Cancer Res. 23, 773 (1963).
Druckrey, H., u. D. Steinhoff: Naturwissenschaften 49, 497 (1962).
Schmähl, D., u. C. Thomas: Naturwissenschaften 52, 165 (1965).
Rapp, H. J., J. H. Carleton, C. Crisler, and E. M. Nadel: J. nat. Cancer Inst. 34, 453 (1965).
Schmähl, D., C. Thomas und G. F. Scheld: Naturwissenschaften 51, 466 (1964).
O‘Gara, R. W., and M. G. Kelly: Proc. Amer. Ass. Cancer Res. 6, 50 (1965).
Stanton, M. F.: J. nat. Cancer Inst. 34, 117 (1965).
Heath, D. F., and A. Dutton: Biochem. J. 70, 619 (1958).
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1966 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Magee, P.N. (1966). Alkylation of Nucleic Acids and Carcinogenesis. In: Holzer, H., Holldorf, A.W. (eds) Molekulare Biologie des Malignen Wachstums. Colloquium der Gesellschaft für Physiologische Chemie am 21./23. April 1966 in Mosbach/Baden, vol 17. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-87539-7_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-87539-7_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-03481-0
Online ISBN: 978-3-642-87539-7
eBook Packages: Springer Book Archive